XML 96 R83.htm IDEA: XBRL DOCUMENT
v3.23.3

Segment Reporting - Retrospective Adjustments to Segment Composition (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues | $ 89,764 | $ 81,159 | $ 263,963 | $ 238,621
Adjusted operating income (loss) | 4,456 | 4,349 | 13,307 | 13,958
Operating Segments | Health Care Benefits |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues | 26,296 | 22,496 | 78,920 | 68,331
Adjusted operating income (loss) | 1,536 | 1,641 | 4,901 | 5,425
Operating Segments | Health Services |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues | 46,891 | 43,254 | 137,697 | 125,807
Adjusted operating income (loss) | 1,878 | 1,695 | 5,452 | 4,996
Operating Segments | Pharmacy & Consumer Wellness |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues | 28,872 | 27,237 | 85,578 | 79,881
Adjusted operating income (loss) | 1,389 | 1,401 | 3,936 | 4,684
Corporate/ Other | Corporate/ Other |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues | 105 | 142 | 376 | 378
Adjusted operating income (loss) | (347) | (388) | (982) | (1,147)
Intersegment Eliminations |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues | (12,400) | (11,970) | (38,608) | (35,776)
Adjusted operating income (loss) | $ 0 | 0 | $ 0 | 0
As Reported |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues |  | 81,159 |  | 238,621
Adjusted operating income (loss) |  | 4,233 |  | 13,526
As Reported | Operating Segments | Health Care Benefits |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues |  | 22,511 |  | 68,376
Adjusted operating income (loss) |  | 1,544 |  | 5,126
As Reported | Operating Segments | Health Services |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues |  | 43,216 |  | 125,489
Adjusted operating income (loss) |  | 1,877 |  | 5,368
As Reported | Operating Segments | Pharmacy & Consumer Wellness |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues |  | 26,706 |  | 78,410
Adjusted operating income (loss) |  | 1,398 |  | 4,865
As Reported | Corporate/ Other | Corporate/ Other |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues |  | 142 |  | 378
Adjusted operating income (loss) |  | (417) |  | (1,277)
As Reported | Intersegment Eliminations |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues |  | (11,416) |  | (34,032)
Adjusted operating income (loss) |  | (169) |  | (556)
Adjustments |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues |  | 0 |  | 0
Adjusted operating income (loss) |  | 116 |  | 432
Adjustments | Operating Segments | Health Care Benefits |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues |  | (15) |  | (45)
Adjusted operating income (loss) |  | 97 |  | 299
Adjustments | Operating Segments | Health Services |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues |  | 38 |  | 318
Adjusted operating income (loss) |  | (182) |  | (372)
Adjustments | Operating Segments | Pharmacy & Consumer Wellness |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues |  | 531 |  | 1,471
Adjusted operating income (loss) |  | 3 |  | (181)
Adjustments | Corporate/ Other | Corporate/ Other |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues |  | 0 |  | 0
Adjusted operating income (loss) |  | 29 |  | 130
Adjustments | Intersegment Eliminations |  |  |  |
Segment Reporting, Other Significant Reconciling Item [Line Items] |  |  |  |
Total revenues |  | (554) |  | (1,744)
Adjusted operating income (loss) |  | $ 169 |  | $ 556

X
- Definition Adjusted Operating Income (Loss) + References No definition available. + Details
Name: | cvs_AdjustedOperatingIncomeLoss
Namespace Prefix: | cvs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-05(b)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingOtherSignificantReconcilingItemLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=cvs_HealthServicesSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyAndConsumerHealthSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=cvs_CorporateAndReconcilingItemsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateAndOtherSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RestatementAxis=srt_RestatementAdjustmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |